Table 5.

Budget impact from the government perspective of introducing four childhood non-National Immunization Program vaccines in China's National Immunization Program

		Children (million)	Total doses (million)*	Market price per dose in 2022 ($)	Total vaccine purchase costs for the central government ($ million)†	Immunisation service costs for the local government ($ million)‡	Total programme costs at market price ($ million)	Total programme costs at 50% reduced market price ($ million)
PCV13		9·56	27·25	68·12	1856·27	98·65	1954·92	1026·79
Pentavalent rotavirus vaccine		9·56	27·25	43·10	1174·48	98·65	1273·13	685·89
Hib vaccine		9·56	27·25	11·62	316·65	98·65	415·30	256·98
Varicella vaccine
	Newborn vaccine	9·56	9·08	20·79	188·77	32·87	221·64	127·26
	Catch-up vaccine	59·00	56·05	20·79	1165·28	202·90	1368·18	785·54

PCV13=13-valent pneumococcal conjugate vaccine. Hib=Haemophilus influenzae serotype b.

^*We assumed a vaccination rate of 95% for all vaccines in China's National Immunization Program.

^†The slight inconsistency in results might be attributed to rounding errors.

^‡An additional $3·62 (CN¥25)/dose was charged as the immunisation service fee.